US 12,344,872 B2
Engineered ligase variants
Mathew G. Miller, San Carlos, CA (US); Jonathan Vroom, South San Francisco, CA (US); Nikki Dellas, Mountain View, CA (US); Donald S. Baskerville, Burlingame, CA (US); Sandy M. Gomes, Redwood City, CA (US); David Elgart, San Mateo, CA (US); and Judy Victoria Antonio Viduya, South San Francisco, CA (US)
Assigned to Codexis, Inc., Redwood City, CA (US)
Filed by Codexis, Inc., Redwood City, CA (US)
Filed on May 7, 2018, as Appl. No. 15/972,919.
Claims priority of provisional application 62/587,030, filed on Nov. 16, 2017.
Claims priority of provisional application 62/540,734, filed on Aug. 3, 2017.
Claims priority of provisional application 62/503,075, filed on May 8, 2017.
Prior Publication US 2018/0320162 A1, Nov. 8, 2018
This patent is subject to a terminal disclaimer.
Int. Cl. C12P 19/34 (2006.01); C12N 9/00 (2006.01); C12Q 1/6806 (2018.01); C40B 40/10 (2006.01)
CPC C12N 9/93 (2013.01) [C12P 19/34 (2013.01); C12Q 1/6806 (2013.01); C12Y 605/01001 (2013.01)] 1 Claim
 
1. An engineered T4 DNA ligase comprising a polypeptide sequence, wherein the polypeptide sequence consists of SEQ ID NO:38.